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Introduction: Factor V Leiden, (F5Q) is the most common inherited risk factor for venous 
thrombosis. However, a relatively small percentage of people carrying F5Q will develop venous 
thrombosis in their lifetimes. This variability results from complex interactions between the 
environment and unknown genetic factors (modifier genes). We previously identified a synthetically 
lethal interaction between mice inheriting two copies of F5Q (F5Q/Q) and partial Tfpi (Tfpi+/-) 
deficiency (F5Q/Q Tfpi+/-). Complete Tfpi deficiency in mice is embryonic lethal, whereas 
heterozygosity is compatible with normal survival. However, all mice inheriting F5Q/Q and Tfpi+/- 
die of thrombosis shortly after birth. 
Methods: The F5Q/Q Tfpi+/- lethal interaction was utilized as the basis for a sensitized ENU 
mutagenesis screen designed to uncover novel dominant suppressor mutations that alter the 
hemostatic balance. Male F5Q/Q mice were ENU mutagenized and bred to F5Q/+ Tfpi+/- double 
heterozygous females. Surviving offspring were analyzed to identify rescued mice with the F5Q/Q 
Tfpi+/- genotype. 
Results: Analysis of 5600 G1 offspring to date has identified 64 mice that survived to weaning. Of 
the 12 F5Q/Q Tfpi+/- mutants tested for heritability, five produced additional F5Q/Q Tfpi+/- 
progeny, demonstrating that the associated thrombosis suppressor is heritable. The latter progeny 
have been genotyped with a panel of markers spanning the genome. For one of these mutant lines, 
this analysis has mapped the corresponding suppressor mutation to a small region on Chromosome 9, 
with fine mapping to identify the corresponding gene underway. 
Conclusions: We have demonstrated the existence of novel dominant mutations that improve 
hemostatic balance leading to survival of F5Q/Q Tfpi+/- mice. Characterization of the genes may 
provide novel insight into the regulation of hemostasis, as well as identifying potential candidates for 
thrombosis modifiers in humans. 
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